Skip to content

Efficacy and safety of ultrasound-guided thermal ablation for hyperthyroidism

Efficacy and safety of ultrasound-guided thermal ablation for hyperthyroidism

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047344
Enrollment
Unknown
Registered
2021-06-12
Start date
2021-06-10
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperthyroidism

Interventions

Hyperthyroidism group:None

Sponsors

People's Liberation Army General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Mild and moderate hyperthyroidism; 3. Mild to moderate thyroid enlargement (the volume of the left and right lobe measured by ultrasound is less than 30 mL); 4. Graves' disease; 5. Toxic multinodular goiter; 6. Autonomous high-functioning adenoma; 7. Diagnosis score of hyperthyroidism crisis < 25; 8. Patients who refuse or are not suitable for radioactive iodine therapy or surgery.

Exclusion criteria

Exclusion criteria: 1. Pre-existing vocal cord paralysis and limited neck movement; 2. Moderate to severely active hyperthyroidism exophthalmos; 3. Patients who plan to become pregnant within 6 months and who are pregnant or breast-feeding; 4. Severe coagulopathy, respiratory failure, myocardial infarction, systemic infection or diabetes are not controlled.

Design outcomes

Primary

MeasureTime frame
Thyroid function;

Countries

China

Contacts

Public ContactLuo Yukun
lixinyang0610@163.com+86 13311373556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026